Organization
GANYMED Pharmaceuticals AG
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
GANYMED Pharmaceuticals AG
... named Özlem Türeci, M.D., as its CMO. Türeci founded and later led Ganymed Pharmaceuticals, which was bought by Astellas for €422 million ($494 million) upfront ...
... of antibodies, as well as vaccine-based therapies. In 2001, Dr. Türeci co-founded Ganymed Pharmaceuticals as Chief Scientific Officer and became its Chief Executive Officer in ...
... ended March 31, 2017. "We achieved multiple milestones including the acquisition of Ganymed last December and an agreement with Ogeda shareholders to acquire Ogeda last ...
... news comes less than six months after Astellas announced it was buying Ganymed Pharmaceuticals, a German biopharmaceutical company, in a deal worth up to $1.4 ...
... "Astellas" ) today announced that it has completed the acquisition of Ganymed Pharmaceuticals AG ("Ganymed"), a biopharmaceutical company located in Mainz, Germany, and Ganymed has ...
... Care Act. ( Kaiser Health News ) 5. Astellas Pharma will acquire Ganymed Pharmaceuticals in a deal worth up $1.4 billion. Ganymed has a portfolio ...
... TARGET COMPANY: 1880339 Ganymed Pharmaceuticals AG SELLERS: 2403873 Seller Group - multiple shareholders ACQUIRER COMPANY: 2032909 Astellas ...
... on its cancer drug offerings. Tokyo-based Astellas announced plans Friday to acquire Ganymed Pharmaceuticals in a deal worth up to $1.4 billion. Astellas will pay ...
... a cancer drug deal Oct. 28. Astellas will acquire privately held Ganymed Pharmaceuticals AG for €422 million ($460.2 million) up front. Shareholders will be eligible ...
... Astellas Pharma Inc has agreed to acquire Ganymed Pharmaceuticals AG, a German biopharmaceutical company focused on developing antibodies against cancer. The ...
Subscribe now for full coverage on GANYMED Pharmaceuticals AG
Start My Free Trial